Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.
Press releases published on June 25, 2025
Vor Bio Announces $175 Million Private Placement
GlobeNewswire
·
June 25, 2025
CAMBRIDGE, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage biotechnology company transforming the treatment of autoimmune diseases, today announced that it has entered into a securities purchase agreement for a private …
Vor Bio Enters into Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset
GlobeNewswire
·
June 25, 2025
-Vor Bio receives ex-Greater China rights to develop and commercialize telitacicept, a novel, dual-target recombinant fusion protein in global Phase 3 development for generalized myasthenia gravis -RemeGen receives initial payment of $125 million …
Main Results of 2025 Annual and Extraordinary General Meeting
GlobeNewswire
·
June 25, 2025
REYKJAVÍK, Iceland and LUXEMBOURG, June 25, 2025 (GLOBE NEWSWIRE) -- The 2025 Annual and Extraordinary General Meeting (the "2025 AGM") of Alvotech (the "Company") was held on June 25, 2025, at Arendt House, 41A Avenue John F. Kennedy, L-2082 Luxembourg, …
Coalition to Improve Access to Cancer Care Applauds Reintroduction of the Cancer Drug Parity Act
GlobeNewswire
·
June 25, 2025
WASHINGTON, June 25, 2025 (GLOBE NEWSWIRE) -- The Coalition to Improve Access to Cancer Care (CIACC) applauds the reintroduction of the Cancer Drug Parity Act, bipartisan legislation that would require group and individual health insurance plans to cover …
Teva to Host Conference Call to Discuss Second Quarter 2025 Financial Results at 8 a.m. ET on July 30, 2025
GlobeNewswire
·
June 25, 2025
TEL AVIV, Israel, June 25, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that it will issue a press release on its second quarter 2025 financial results on Wednesday, July 30, 2025, at 7:00 a.m. ET. …
Cancer Immunotherapy Market Set to Witness Significant Growth by 2025-2032: Bristol-Myers Squibb Company, Pfizer Inc
EIN Presswire
·
June 25, 2025
BURLINGAME, CA, UNITED STATES, June 25, 2025 /EINPresswire.com/ -- Global cancer immunotherapy market is estimated to be valued at USD 158.42 Bn in 2025 and is expected to reach USD 357.07 Bn by 2032, exhibiting a compound annual growth rate (CAGR) of …
Reviva Pharmaceuticals Holdings, Inc. Announces Proposed Public Offering
GlobeNewswire
·
June 25, 2025
CUPERTINO, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (“Reviva” or the “Company”), a late-stage pharmaceutical company developing therapies that seek to address unmet medical needs in the areas of central …
DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide.
GlobeNewswire
·
June 25, 2025
Châtillon, France, le 25 juin (22 :30 CEST) 2025 DBV Technologies annonce le screening du premier sujet de l'étude complémentaire d’innocuité COMFORT Toddlers chez les enfants âgés de 1 à 3 ans allergiques à l’arachide. Screening du premier sujet à l' …
DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old
GlobeNewswire
·
June 25, 2025
Châtillon, France, June 25, 2025 DBV Technologies Announces First Subject Screened in COMFORT Toddlers Supplemental Safety Study in Peanut Allergic Toddlers 1 – 3 Years Old First subject screened at the Respiratory Medicine Research Institute of Michigan …
Plus Therapeutics to Provide Business Update and Host Conference Call on Thursday, June 26, 2025 at 9:00 A.M. ET
GlobeNewswire
·
June 25, 2025
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform technologies for central nervous system (CNS) cancers, …
Option Care Health to Announce Second Quarter 2025 Financial Results and Host Conference Call
GlobeNewswire
·
June 25, 2025
BANNOCKBURN, Ill., June 25, 2025 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation’s largest independent provider of home and alternate site infusion services, today announced that the company will release …
Kymera Therapeutics Announces Proposed Public Offering
GlobeNewswire
·
June 25, 2025
WATERTOWN, Mass., June 25, 2025 (GLOBE NEWSWIRE) -- Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that it has …
Maravai LifeSciences Appoints Rajesh Asarpota as Chief Financial Officer
GlobeNewswire
·
June 25, 2025
SAN DIEGO, June 25, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today announced that Rajesh “Raj” Asarpota has been appointed …
Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City
GlobeNewswire
·
June 25, 2025
IRVINE, Calif., June 25, 2025 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (Nasdaq: ELDN) today announced that it will host an R…
Neurosculpting Institute Announces Peer-Reviewed Study Linking Neurosculpting Meditation to Improved Clinical Accuracy in Dental Students
GlobeNewswire
·
June 25, 2025
Denver, CO , June 25, 2025 (GLOBE NEWSWIRE) -- The Neurosculpting® Institute, a meditation and neuroplasticity education organization, announced the publication of a peer-reviewed study in the Cureus Journal of Medical Science showing that undergraduate …
Lipella Pharmaceuticals Issues Letter from the CEO to Stockholders Following Nasdaq Delisting
GlobeNewswire
·
June 25, 2025
PITTSBURGH, June 25, 2025 (GLOBE NEWSWIRE) -- Lipella Pharmaceuticals Inc. (OTC: LIPO) (“Lipella” or the “Company”), a clinical-stage biotechnology company focused on developing therapies for diseases with significant unmet need, today issued a letter from …
Global mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2032 | DelveInsight
GlobeNewswire
·
June 25, 2025
New York, USA, June 25, 2025 (GLOBE NEWSWIRE) -- Global mRNA Synthesis and Manufacturing Market to Increase at a Steady Growth Rate of ~4% by 2032 | DelveInsight The growing incidence of infectious diseases, cancer, and chronic illnesses has substantially …
CHESS Health Rewards Engine: A Better Way to Fight Stimulant Crisis Across Colorado
GlobeNewswire
·
June 25, 2025
Rochester, New York, June 25, 2025 (GLOBE NEWSWIRE) -- CHESS Health is partnering with Porch Light HealthⓇ (PLH) to offer its innovative, automated contingency management Rewards Engine for treating individuals with substance use disorder (SUD). PLH’s …
Gold H2 Delivers First Successful Subsurface Bio-Stimulated Hydrogen Production Field Trial
GlobeNewswire
·
June 25, 2025
HOUSTON, June 25, 2025 (GLOBE NEWSWIRE) -- Gold H2, a climate tech energy company, today announced the successful completion of the world’s first field trial demonstrating subsurface bio-stimulated hydrogen production. Conducted in a legacy oilfield in …
Valneva Announces Successful Outcome of its Annual General Meeting, Confirms FY 2025 guidance
GlobeNewswire
·
June 25, 2025
Saint-Herblain (France), June 25, 2025 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Board of Directors were approved by the shareholders at its Annual General …